Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS (Q28278903)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Christian Pállson Nolsøe

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Fabio Piscaglia

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Richard G. Barr

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Nitin G Chaubal

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Dirk Andre Clevert

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Jeffrey Fowlkes

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Michel Claudon

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Christoph F Dietrich

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

David O Cosgrove

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Stephanie R Wilson

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Maria C Chammas

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Min-Hua Chen

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Jean Michel Correas

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Flemming Forsberg

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Robert N Gibson

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Barry B Goldberg

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Nathalie Lassau

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Edward L S Leen

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Robert F Mattrey

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Fuminori Moriyasu

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Hans-Peter Weskott

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Hui-Xiong Xu

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

World Federation for Ultrasound in Medicine

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

European Federation of Societies for Ultrasound

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

0 references

publication date

5 November 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

number of pages

24

1 reference

based on heuristic

inferred from page(s)

Ultrasound in Medicine and Biology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

39

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

187-210

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Repeat hepatectomy for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Guidelines for the use of contrast agents in ultrasound. January 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Ultrasound contrast imaging research

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Clinical utility of microbubble contrast-enhanced ultrasound in the diagnosis of hepatic artery occlusion after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography—A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Background subtraction from time-intensity curves in videodensitometry: a pitfall in flow assessment using contrast echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue® low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

The nodular form of hepatic tuberculosis: contrast-enhanced ultrasonographic findings with pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Transient hepatic echogenicity difference on contrast-enhanced ultrasonography: sonographic sign and pitfall

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Low mechanical index contrast-enhanced sonographic findings of pyogenic hepatic abscesses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Detection of colorectal liver metastases using intraoperative ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

The role of contrast-enhanced ultrasound on the diagnosis of small hepatocellular carcinoma (</=3cm) in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Treatment strategy to optimize radiofrequency ablation for liver malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-enhanced ultrasound in liver transplant: first results and potential for complications in the postoperative period

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Clinical uses of microbubbles in diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Imaging of perfusion using ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Targeting liver lesions for radiofrequency ablation: an experimental feasibility study using a CT-US fusion imaging system

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-enhanced ultrasound of histologically proven liver hemangiomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Hepatic artery stenosis and thrombosis in transplant recipients: Doppler diagnosis with resistive index and systolic acceleration time

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Minimum training requirements for the practice of Medical Ultrasound in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Intraoperative ultrasonography during planned liver resections: why are we still performing it?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Angiogenesis as a therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Growth rate of hepatic metastases in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Additional value of contrast enhanced intraoperative ultrasound for colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Duplex sonography of hepatic artery thrombosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Role of contrast-enhanced ultrasonography in primary hepatic lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Sonazoid-Enhanced Ultrasonography for Diagnosis of Hepatic Malignancies: Comparison with Contrast-Enhanced CT

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Hemodynamic changes on color Doppler flow imaging and intravenous contrast-enhanced ultrasound for assessing transplanted liver and early diagnosis of complications

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

A benign tumour of the liver mimicking malignant liver disease--cholangiocellular adenoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Imaging of Hepatocellular Carcinoma: Qualitative and Quantitative Analysis of Postvascular Phase Contrast-Enhanced Ultrasonography with Sonazoid

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Long-Term Survival After Liver Transplantation in 4,000 Consecutive Patients at a Single Center

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Compounds in clinical Phase III and beyond

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Meta-analysis of adverse cardiovascular events associated with echocardiographic contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-enhanced ultrasonography in patients with colorectal liver metastases after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-enhanced ultrasonography to detect liver metastases : a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Double-Contrast Ultrasound: A Novel Surveillance Tool for Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Newly Developed Novel Ultrasound Technique, Defect Reperfusion Ultrasound Imaging, Using Sonazoid in the Management of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: pilot study using dynamic contrast-enhanced Doppler ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Vascular complications after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: a prospective double-blinded study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Quantitative functional imaging by Dynamic Contrast Enhanced Ultrasonography (DCE-US) in GIST patients treated with masatinib

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Advanced Hepatocellular Carcinoma: Early Evaluation of Response to Bevacizumab Therapy at Dynamic Contrast-enhanced US with Quantification—Preliminary Results 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Canine prostate: contrast-enhanced US-guided radiofrequency ablation with urethral and neurovascular cooling--initial experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Radiofrequency tumor ablation: insight into improved efficacy using computer modeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Role of contrast-enhanced ultrasound in decision support for diagnosis and treatment of hepatic artery thrombosis after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

CEUS: a new imaging approach for postoperative vascular complications after right-lobe LDLT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Ultrasound contrast agents: balancing safety versus efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients).

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Detection and characterization of hepatocellular carcinoma by imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Intra-operative ultrasound for detection of liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Primum non nocere? Why can't we use second generation ultrasound contrast agents for the examination of children?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Value of contrast-enhanced intraoperative ultrasound for cirrhotic patients with hepatocellular carcinoma: a report of 20 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-Enhanced Versus Conventional and Color Doppler Sonography for the Detection of Thrombosis of the Portal and Hepatic Venous Systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Resection of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

[The infammatory pseudotumour -- an unusual liver tumour]

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Ultrasound of non-vascular complications in the post liver transplant patient.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Microbubble ultrasound contrast in the assessment of hepatic artery patency following liver transplantation: role in reducing frequency of hepatic artery arteriography.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial).

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Real-time myocardial contrast echocardiography in rat: infusion versus bolus administration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Real-Time Contrast Echo Assessment of Myocardial Perfusion at Low Emission Power: First Experimental and Clinical Results Using Power Pulse Inversion Imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-enhanced intraoperative ultrasonography: a valuable and not any more monocentric diagnostic technique performed in different ways

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Imaging features of hepatic angiomyolipomas on real-time contrast-enhanced ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Contrast-enhanced ultrasound for the evaluation of hepatic artery stenosis after liver transplantation: potential role in changing the clinical algorithm.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2012.09.002

7 January 2021

Identifiers

10.1016/J.ULTRASMEDBIO.2012.09.002

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23137926%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28278903&oldid=2034585038"